Article Sidebar
Published:
Jul 7, 2021Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Indomethacin inhibits PGE2, regulates inflammatory response, participates in adipogenesis regulation, and improves success rate of fat transplantation in C57/B6 mice
Abstract
Purpose: To investigate the effect of indomethacin on prostaglandin E2, regulation of inflammation and adipogenesis, and success of fat transplantation in mice.
Methods: The mice were randomly divided into 4 groups: group A (free fat group), group B (free fat + stromal vascular fragments group (SVF)), group C (free fat + 200 μM indomethacin group), and group D (free fat + 200 μM indomethacin + SVF group), with 21 mice in each group. Expression levels of adipogenic genes CEBP-α, FABP4 and LPL in each group were determined. Changes in PGE2 level in transplanted adipose tissue, and changes in the expression of NF-κB in apoptotic stem cells induced by different pro-inflammatory treatments were assayed.
Results: Compared with group B, the expression levels of adipogenic genes CEBP-α, FABP4 and LPL significantly decreased in groups A, C and D, with group A as the lowest (p < 0.05). Compared with the indomethacin treatment group, the level of inhibition of PGE2 in mice adipose tissue in the indomethacin-free group increased significantly (p < 0.01). The expression of NF-κB in the adipose stem cells from the indomethacin-treated group was significantly lower than that in the indomethacin-treated group after pretreatment with IL-17 or INF-γ + TNF-α.
Conclusion: Indomethacin regulates adipogenesis by inhibiting the production of COX2 metabolite, PGE2. It also regulates the local microenvironment, inhibits the inflammatory process, and protects various stem cells. Therefore, it may improve the success rate of fat transplantation.
